{'52WeekChange': 0.28328168,
 'SandP52WeekChange': None,
 'address1': '42 Hayarkon Street',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 4.05,
 'askSize': 1000,
 'averageDailyVolume10Day': 115837,
 'averageVolume': 173773,
 'averageVolume10days': 115837,
 'beta': 1.517086,
 'beta3Year': None,
 'bid': 3.8,
 'bidSize': 3000,
 'bookValue': 0.474,
 'category': None,
 'circulatingSupply': None,
 'city': 'Yavne',
 'companyOfficers': [],
 'country': 'Israel',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 4.2,
 'dayLow': 3.98,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 10.876,
 'enterpriseToRevenue': 2.488,
 'enterpriseValue': 88975128,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '972 7 797 14111',
 'fiftyDayAverage': 3.0597143,
 'fiftyTwoWeekHigh': 4.28,
 'fiftyTwoWeekLow': 1.443,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 17121242,
 'forwardEps': -0.24,
 'forwardPE': -17.208334,
 'fromCurrency': None,
 'fullTimeEmployees': 74,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.41955003,
 'heldPercentInstitutions': 0.25642002,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/mediwound.com',
 'longBusinessSummary': 'MediWound Ltd., an integrated biopharmaceutical '
                        'company, focuses on developing, manufacturing, and '
                        'commercializing novel therapeutics products to '
                        'address unmet needs in the fields of severe burns, '
                        'chronic and other hard-to-heal wounds, connective '
                        'tissue disorders, and other indications. It markets '
                        'NexoBrid, a biopharmaceutical product for the removal '
                        'of eschar, a dead or damaged tissue in adults with '
                        'deep partial- and full-thickness thermal burns to '
                        'burn centers and hospitals burn units. The company '
                        'also develops EscharEx, which has completed Phase II '
                        'clinical trials for the debridement of chronic and '
                        'other hard-to-heal wounds; and MWPC003 for connective '
                        'tissue disorders. MediWound Ltd. was founded in 2000 '
                        'and is headquartered in Yavne, Israel.',
 'longName': 'MediWound Ltd.',
 'market': 'us_market',
 'marketCap': 112381848,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_1570881',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 3765000,
 'nextFiscalYearEnd': 1640908800,
 'open': 4.19,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.1,
 'phone': '972 7 797 14100',
 'previousClose': 4.145,
 'priceHint': 4,
 'priceToBook': 8.71308,
 'priceToSalesTrailing12Months': 3.1421418,
 'profitMargins': 0.18464,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 4.2,
 'regularMarketDayLow': 3.98,
 'regularMarketOpen': 4.19,
 'regularMarketPreviousClose': 4.145,
 'regularMarketPrice': 4.19,
 'regularMarketVolume': 67621,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 27211100,
 'sharesPercentSharesOut': 0.0015,
 'sharesShort': 41948,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 47069,
 'shortName': 'MediWound Ltd.',
 'shortPercentOfFloat': 0.0032,
 'shortRatio': 0.19,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'MDWD',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 0.243,
 'trailingPE': 16.995886,
 'twoHundredDayAverage': 2.4940288,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '1d731941-74dc-3c53-8065-5808c744e4bc',
 'volume': 67621,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.mediwound.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '8122745'}